Cargando…
Validation of a novel UPLC-HRMS method for human whole-blood cyclosporine and comparison with a CMIA immunoassay
Therapeutic drug monitoring is an essential tool when managing the therapeutic use of immunosuppressant cyclosporine A (CsA) in cases with solid organ transplantation. In China, the concentration of CsA is primarily measured using immunoassays. However, existing literature recommends mass spectromet...
Autores principales: | Wang, Xiaoxue, Qin, Wei, Chen, Wenqian, Liu, Huifang, Zhang, Dan, Zhang, Xianglin, Li, Pengmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812591/ https://www.ncbi.nlm.nih.gov/pubmed/33488800 http://dx.doi.org/10.3892/etm.2021.9623 |
Ejemplares similares
-
Evaluation of the Abbott Alinity i Thyroid-Stimulating Hormone Receptor Antibody (TRAb) Chemiluminescent Microparticle Immunoassay (CMIA)
por: Lee, Deborah J. W., et al.
Publicado: (2023) -
The analyzation and clinical evaluation of ECLIA and CMIA in the detection of Treponema pallidum
por: Zhou, Jiansuo, et al.
Publicado: (2017) -
Biomarker discovery in galactosemia: Metabolomics with UPLC/HRMS in dried blood spots
por: Alodaib, Ahmad N., et al.
Publicado: (2023) -
Establishment and validation of analytical methods for 15 hazardous drugs by UPLC-Q/Orbitrap-HRMS
por: Yu, Bo, et al.
Publicado: (2022) -
An automatic UPLC‐HRMS data analysis platform for plant metabolomics
por: Liu, Pingping, et al.
Publicado: (2019)